Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial
Luc Bergougnan, View ORCID ProfileGrit Andersen, Leona Plum-Mörschel, View ORCID ProfileMaria Francesca Evaristi, View ORCID ProfileBruno Poirier, Agnes Tardat, Marcel Ermer, View ORCID ProfileTheresa Herbrand, View ORCID ProfileJorge Arrubla, Hans Veit Coester, View ORCID ProfileRoberto Sansone, View ORCID ProfileChristian Heiss, Olivier Vitse, View ORCID ProfileFabrice Hurbin, View ORCID ProfileRania Boiron, View ORCID ProfileXavier Benain, David Radzik, View ORCID ProfilePhilip Janiak, View ORCID ProfileAnthony J Muslin, Lionel Hovsepian, Stephane Kirkesseli, Paul Deutsch, View ORCID ProfileAshfaq A Parkar
doi: https://doi.org/10.1101/2020.05.15.20103101
Luc Bergougnan
1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
Grit Andersen
2Profil Institut für Stoffwechselforschung GmbH, Hellersbergstraße 9, 41460 Neuss, Germany
Leona Plum-Mörschel
3Profil Mainz GmbH & Co. KG, Malakoff-Passage, Rheinstraße 4C, Eingang via Templerstraße, D-55116 Mainz, Germany
Maria Francesca Evaristi
1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
Bruno Poirier
1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
Agnes Tardat
4Sanofi R&D, 371 Rue du Professeur Blayac, 34080 Montpellier, France
Marcel Ermer
3Profil Mainz GmbH & Co. KG, Malakoff-Passage, Rheinstraße 4C, Eingang via Templerstraße, D-55116 Mainz, Germany
Theresa Herbrand
2Profil Institut für Stoffwechselforschung GmbH, Hellersbergstraße 9, 41460 Neuss, Germany
Jorge Arrubla
2Profil Institut für Stoffwechselforschung GmbH, Hellersbergstraße 9, 41460 Neuss, Germany
Hans Veit Coester
2Profil Institut für Stoffwechselforschung GmbH, Hellersbergstraße 9, 41460 Neuss, Germany
Roberto Sansone
5University Hospital Düsseldorf, Division of Cardiology, Pulmonary diseases and Vascular medicine, 40225 Düsseldorf, Germany
Christian Heiss
6Department of Clinical and Experimental Medicine, University of Surrey, Stag Hill, Guildford GU2 7XH, UK
Olivier Vitse
4Sanofi R&D, 371 Rue du Professeur Blayac, 34080 Montpellier, France
Fabrice Hurbin
4Sanofi R&D, 371 Rue du Professeur Blayac, 34080 Montpellier, France
Rania Boiron
1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
Xavier Benain
4Sanofi R&D, 371 Rue du Professeur Blayac, 34080 Montpellier, France
David Radzik
1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
Philip Janiak
1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
Anthony J Muslin
7Sanofi US Services, 640 Memorial Drive, Cambridge MA 02139, USA
Lionel Hovsepian
1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
Stephane Kirkesseli
1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
Paul Deutsch
8Sanofi US Services, 55 Corporate Drive, Bridgewater, NJ 08807, USA
Ashfaq A Parkar
8Sanofi US Services, 55 Corporate Drive, Bridgewater, NJ 08807, USA
Article usage
Posted May 20, 2020.
Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial
Luc Bergougnan, Grit Andersen, Leona Plum-Mörschel, Maria Francesca Evaristi, Bruno Poirier, Agnes Tardat, Marcel Ermer, Theresa Herbrand, Jorge Arrubla, Hans Veit Coester, Roberto Sansone, Christian Heiss, Olivier Vitse, Fabrice Hurbin, Rania Boiron, Xavier Benain, David Radzik, Philip Janiak, Anthony J Muslin, Lionel Hovsepian, Stephane Kirkesseli, Paul Deutsch, Ashfaq A Parkar
medRxiv 2020.05.15.20103101; doi: https://doi.org/10.1101/2020.05.15.20103101
Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial
Luc Bergougnan, Grit Andersen, Leona Plum-Mörschel, Maria Francesca Evaristi, Bruno Poirier, Agnes Tardat, Marcel Ermer, Theresa Herbrand, Jorge Arrubla, Hans Veit Coester, Roberto Sansone, Christian Heiss, Olivier Vitse, Fabrice Hurbin, Rania Boiron, Xavier Benain, David Radzik, Philip Janiak, Anthony J Muslin, Lionel Hovsepian, Stephane Kirkesseli, Paul Deutsch, Ashfaq A Parkar
medRxiv 2020.05.15.20103101; doi: https://doi.org/10.1101/2020.05.15.20103101
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)